Risk adjustment models allow stratifying the population, considering chronic disease as a predictor of drug costs. In this paper, we analyze outpatient drug spending using Clinical Risk Groups (CRG) to obtain patient risk ...

[EN] Problem: In the current context of budget constraints in the health sector management systems that allow allocating spending more efficiently are required. In the case of pharmaceutical expenditure, risk adjustment ...

OBJECTIVE To determine the prevalence of patients with diabetes mellitus (DM2) in Valencia. Moreover, the analysis of population characteristics, disease profile, multimorbidity, pharmaceutical costs, resource consumption ...

Background Pharmaceutical expenditure is undergoing very high growth, and accounts for 30% of overall healthcare expenditure in Spain. In this paper we present a prediction model for primary health care pharmaceutical ...